Correspondence 0001493152-23-018531 from Genenta Science S.p.A. (GNTA) (CIK 0001838716) (GNTA)
Genenta Science S.p.A. (GNTA) (CIK 0001838716)
Date: May 22, 2023 · CIK: 0001838716 · Accession: 0001493152-23-018531
AI Filing Summary & Sentiment
File numbers found in text: 333-271901
Show Raw Text
CORRESP
1
filename1.htm
GENENTA
SCIENCE S.P.A.
Olgettina
No. 58
20132
Milan, Italy
May
22, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Attention:
Cindy
Polynice
Re:
Genenta
Science S.p.A.
Registration
Statement on Form F-3 (File No. 333-271901) filed May 12, 2023.
Requested
Date: May 24, 2023
Requested
Time: 4:30 PM Eastern Time
Ladies
and Gentlemen:
Genenta
Science S.p.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to declare the above-captioned Registration Statement on Form F-3 effective at the “Requested Date”
and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally
request via telephone call to the staff of the Commission.
The
Registrant hereby authorizes Per Chilstrom, who is an attorney with the Registrant’s outside legal counsel, Fenwick & West
LLP, to orally modify or withdraw this request for acceleration.
The
Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Chilstrom at (212) 430-2669.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
Sincerely,
Genenta
Science S.p.A.
By:
/s/
Pierluigi Paracchi
Pierluigi
Paracchi
Chief
Executive Officer
cc:
Richard
B. Slansky, Chief Financial Officer
Genenta
Science S.p.A.
Per
B. Chilstrom, Esq.
Fenwick
& West LLP